Optimal Pathway Groups

Our Optimal Pathway Groups are bringing together clinicians, managers, commissioners and patients to ensure the achievement of best possible outcomes for patients. They take a whole pathway approach from prevention through treatment to living with and beyond cancer.

There are currently eight tumour site Optimal Pathway Groups (OPGs) - Breast; Colorectal; Gynaecology; Head and Neck; Lung; Hepatobiliary (HPB); Upper Gastrointestinal (GI) and Urology.

Click on each of the links above to view information specific to each individual OPG.

Each of the Optimal Pathway Groups is led by a Clinical Director. Click here for more information.

Their work is being overseen by the newly-constituted Clinical Advisory Board. More information here.

A further two - haematology and skin - are still to be established and there are currently vacancies for a Clinical Director for each. Click here for more information and to view the Role Description.

Administrative and project support for the Optimal Pathways Groups has now transferred to a dedicated team, hosted by Calderdale and Huddersfield NHS Foundation Trust.

The team, pictured below right, is led by Programme Manager Randolph Haggerty and will help to support and progress the work being delivered by the OPGs. Click here for more information about team members and their contact details.

For further information and enquiries relating to the Optimal Pathway Groups, please contact 07881 359133.

Programme management oversight remains with Ingrid Ablett-Spence, Cancer Alliance Optimal Pathways Programme Manager (below far right), and Charlotte Houston, Project Manager (below far left). Also pictured is Cancer Alliance Lead Professor Sean Duffy and Programme Analyst Katie Lees.

Email: i.ablett-spence@nhs.net, or call 07929 368219.